ST.27-legal status data

The legal status information displayed below is based on WIPO Standard ST.27 and of a purely informative nature. Binding information on the status of the IP right is only available in DPMAregister (Show details).

DE file number: 602 50 269.1, EP file number: 18 15 5722.4 (Designation/title: RAPAMYCINDERIVAT ZUR BEHANDLUNG VON FESTEN TUMOREN)

↩ Details

Tabular representation
Current state: Not active, Current state: Grant

Key event history
No. Key Event Code Key Event Name Event Date Effective Date Effective Date sorted ascending Publication Date To Stage
1 Q10 Document published Jul 11, 2018Jul 11, 2018 Filing
2 Q10 Document published Aug 23, 2018Aug 23, 2018Aug 23, 2018 Filing
3 H10 IP right ceased Feb 18, 2022Feb 18, 2022 Termination likely/termination
4 Q10 Document published Apr 6, 2022Apr 6, 2022 Examination
5 Q10 Document published Apr 21, 2022Apr 21, 2022Apr 21, 2022 Examination
6 E10 Pre-grant review requested Jan 4, 2023Jan 4, 2023Feb 23, 2023 Pre-grant challenge
7 F10 IP right granted Feb 6, 2025Feb 6, 2025Jun 26, 2025 Grant
Detailed event history
No. Detailed Event Code Detailed Event Name Event Date Effective Date Effective Date sorted ascending Publication Date To Stage
1 Q12 Application published Jul 11, 2018Jul 11, 2018 Filing
2 Q10 Document published Aug 23, 2018Aug 23, 2018Aug 23, 2018 Filing
3 H14 IP right expired Feb 18, 2022Feb 18, 2022 Termination likely/termination
4 Q10 Document published Apr 6, 2022Apr 6, 2022 Examination
5 Q10 Document published Apr 21, 2022Apr 21, 2022Apr 21, 2022 Examination
6 E11 Pre-grant opposition filed Jan 4, 2023Jan 4, 2023Feb 23, 2023 Pre-grant challenge
7 F13 IP right granted in full following pre-grant review Feb 6, 2025Feb 6, 2025Jun 26, 2025 Grant

Graphical representation

Below you will see a simplified graphical representation of the legal status information, which is based on WIPO Standard ST.27 using the "Overall Patent/SPC Prosecution Model" defined therein.

Graphical representation of the ST.27 legal status data is not possible.